Cell wall synthesis inhibitors
Cell Wall Synthesis Inhibitors
•
Penicillins
•
Cephalosporins
•
Monobactams
•
Carbapenems
•
Glycopeptides
•
Other Cell Wall-
or Membrane-Active Agents
BETA-LACTAM ANTIBIOTICS
(inhibitors of cell wall synthesis)
Their structure contains a
beta-lactam ring.
The major
subdivisions are:
penicillins whose official names usually include or
end in “cillin”
b.
cephalosporins
which are recognized by the inclusion of “cef” or “ceph” in their official
names.
c.
carbapenems (e.g.
meropenem, imipenem)
d.
monobactams (e.g.
aztreonam)
e.
beta-lactamase
inhibitors (e.g. clavulanic acid, sulbactam).
Chemical
Structure
Penicillins
•
In 1928, Alexander
Fleming was researching vaccines and noticed a culture of staphlococci had
undergone lysis from contamination with a mold
•
Fleming finally
isolated the mold, Penicillium notatum, and found that the fluid beneath
it possessed antibacterial properties
•
Basic structure
consists of thiazolidine ring connected to b-lactam ring, to which is attached
a side chain
Structure of penicillins and products of
their enzymatic hydrolysis:
Chemical
structure, major variants
Classification of penicillins
Penicillins are subclassed based on
chemical structure
(eg, penicillins, monobactams, and
carbapenems),
spectrum (narrow,
broad, or extended)
source (natural,
semisynthetic, or synthetic) and
susceptibility to β-lactamase destruction.
Classes by
Spectrum
Narrow-spectrum
β-Lactamase-Sensitive Penicillins
Penicillin G
(benzylpenicillin); penicillin V [phenoxymethyl-penicillin] and phenethicillin.
These are active
against many gram-positive and a limited number of gram-negative bacteria, as
well as anaerobic organisms, but they are susceptible to β-lactamase
(penicillinase) hydrolysis.
Narrow-spectrum
β-Lactamase-Resistant Penicillins
This group,
through substitution on the penicillin nucleus (6-aminopenicillanic acid), is
refractory to a greater or lesser degree to the effects of various β-lactamase
enzymes produced by resistant gram-positive organisms, particularly
Staphylococcus aureus.
However,
penicillins in this class are not as active against many gram-positive bacteria
as penicillin G and are inactive against almost all gram-negative bacteria.
Acid-stable
members of this group may be given orally and include isoxazolyl penicillins,
such as oxacillin, cloxacillin, dicloxacillin, and flucloxacillin.
Methicillin and nafcillin
are available as parenteral preparations.
Temo-cillin is a
semisynthetic penicillin that is β-lactamase stable but also active against
nearly all isolates of gram-negative bacteria except Pseudomonas spp.
Broad-spectrum
β-Lactamase-Sensitive Penicillins
Penicillins in
this class are derived semisynthetically and are active against many
gram-positive and gram-negative bacteria. However, they are readily destroyed
by the β-lactamases (produced by many bacteria).
Many members of
the group are acid stable and are administered either PO or parenterally.
Of those used in
veterinary medicine, aminopenicillins, eg, ampicillin and amoxicillin, are the
best known. Several ampicillin precursors that are more completely absorbed
from the GI tract also belong to this class (eg, hetacillin, pivampicillin,
talampicillin). Mecillinam is less active than ampicillin against gram-positive
bacteria but is highly active against many intestinal organisms (except Proteus
spp) that do not produce β-lactamases.
Broad-spectrum
β-Lactamase-Sensitive Penicillins with Extended Spectra
Several
semisynthetic broad-spectrum penicillins are also active against Pseudomonas
aeruginosa, certain Proteus spp, and even strains of Klebsiella, Shigella, and
Enterobacter spp in certain cases. Examples of this class include carboxypenicillins
(carbenicillin, its acid-stable indanyl ester, and ticarcillin), ureido-penicillins
(azlocillin and mezlocillin), and piperazine penicillins (piperacillin).
β-Lactamase-Protected
Broad-Spectrum Penicillins
Several naturally
occurring and semisynthetic compounds can inhibit many of the β-lactamase
enzymes produced by penicillin-resistant bacteria.
When used in
combination with broad-spectrum penicillins, there is a notable synergistic
effect because the active penicillin is protected from enzymatic
hydrolysis—and thus is fully active against a wide variety of previously
resistant bacteria.
Examples of this
chemotherapeutic approach include clavulanate-potentiated amoxicillin and
ticarcillin as well as sulbactam-potentiated ampicillin and
tazobactam-potentiated piperacillin.
Carbapenems
Imipenem and meropenem
are among the most active drugs against a wide variety of bacteria.
Imipenem is
derived from a compound produced by Streptomyces cattleya.
Aztreonam is a
related (monobactam) compound but differs from other β-lactams in that it has a
second ring that is not fused to the β-lactam ring.
Antibacterial Spectrum
Natural penicillins
Penicillin G
(Benzylpenicillin)
•
Gram +/- cocci,
Gram + bacilli, spirochetes, anaerobes
•
Susceptible to
inactivation by b-lactamase
Penicillin V
•
Similar spectrum
•
More acid stable
than Pen G
•
Higher minimum
inhibitory concentration
Bacteria Susceptible to Penicillin
Strep pneumonia - Major cause of bacterial
pneumonia in all ages
Gonorrhea - Neisseria gonorrhea and
meningitidis
Syphilis - Treponema pallidum
Antistaphylococcal penicillins
Methicillin
Nafcillin
Oxacillin
Dicloxacillin
All are penicillinase-resistant penicillins used in
penicillinase-producing staphylococci
Methicillin-resistant staph aureus
Extended spectrum penicillins
Ampicillin
Amoxicillin
Activity against haemophilus influenza, proteus mirabilis, E. coli, and
neisseria species
Resistance due to plasmid mediated penicillinase
May use clavulanic acid or sulbactam to extend the antibacterial
activity
Antipseudomonal penicillins
Carbenicillin
Ticarcillin
Piperacillin
Azlocillin
Mezlocillin
Effective against pseudomonas aeroginosa and other gram negatives
General
Properties
The penicillins are
somewhat unstable, being sensitive to heat, light, extremes in pH, heavy
metals, and oxidizing and reducing agents. Also, they often deteriorate in
aqueous solution and require reconstitution with a diluent just before
injection. Penicillins are poorly soluble, weak organic acids that are
administered parenterally either as suspensions in water or oil, or as
water-soluble salts. For example, sodium or potassium salts of penicillin G are
highly water soluble and are absorbed rapidly from injection sites, whereas
organic esters in microsuspension such as procaine penicillin G or benzathine
penicillin G are gradually absorbed over 1–3 (or even more) days, respectively.
The trihydrate forms of the semisynthetic penicillins have greater aqueous
solubility than the parent compounds and are usually preferred for both
parenteral and oral use.
Penicillins contain a
β-lactam nucleus that when cleaved by a β-lactamase enzyme (penicillinase)
produces penicilloic acid derivatives that are inactive but may act as the
antigenic determinants for penicillin hypersensitivity. Modification of the
6-aminopenicillanic acid nucleus, either by biosynthetic or semisynthetic
means, has produced the array of penicillins used clinically. These differ in
their antibacterial spectra, pharmacokinetic characteristics, and
susceptibility to microbial enzymatic degradation.
Penicillin G and its
oral congeners (eg, penicillin V) are active against both aerobic and anaerobic
gram-positive bacteria and, with a few exceptions (Haemophilus and Neisseria
spp and strains of Bacteroides other than B fragilis), are inactive against
gram-negative organisms at usual concentrations. Organisms usually sensitive in
vitro to penicillin G include streptococci, penicillin-sensitive staphylococci,
Arcanobacterium pyogenes, Clostridium spp, Erysipelothrix rhusiopathiae,
Actinomyces bovis, Leptospira canicola, Bacillus anthracis, Fusiformis nodosus,
and Nocardia spp.
The semisynthetic
β-lactamase-resistant penicillins, such as oxacillin, cloxacillin, floxacillin,
and nafcillin, have spectra similar to those noted above (although often at
higher MIC) but also include many of the β-lactamase-producing strains of
staphylococci (especially S aureus and S epidermidis).
A large number of
gram-positive and gram-negative bacteria (but not β-lactamase-producing
strains) are sensitive to the semisynthetic broad-spectrum penicillins
(ampicillin and amoxicillin). Susceptible genera include Staphylococcus,
Streptococcus, Arcanobacterium, Clostridium, Escherichia, Klebsiella, Shigella,
Salmonella, Proteus, and Pasteurella. While bacterial resistance is widespread,
the combination of β-lactamase inhibitors and broad-spectrum penicillins
markedly enhances the spectrum and efficacy against both gram-positive and
gram-negative pathogens. Clavulanate-potentiated amoxicillin is an excellent
example of such a synergistic association.
The anti-Pseudomonas
and other extended-spectrum penicillins are active against most of the usual
penicillin-sensitive bacteria. They often have a degree of β-lactamase
resistance and are usually active against one or more characteristic
penicillin-resistant organisms. Yet, as a class, they remain susceptible to
destruction by β-lactamases. Examples include the use of carbenicillin,
ticarcillin, and piperacillin against Pseudomonas aeruginosa and several
Proteus strains, and the use of piperacillin against Pseudomonas aeruginosa,
several Shigella and Proteus strains, and some Citrobacter and Enterobacter
spp. Streptococcus faecalis is often resistant to these new extended-spectrum
penicillins. Imipenem and meropenem are relatively resistant to β-lactamase
destruction. Their spectrum includes a wide variety of aerobic and anaerobic
microorganisms, including most strains of Pseudomonas, streptococci,
enterococci, staphylococci, and Listeria. Anaerobes, including Bacteroides
fragilis, are highly susceptible.
Difference between Gram +ve and –ve
bacteria in their cell wall structure
Cell envelope of a gram-negative bacterium
The cell wall completely surrounds the
cytoplasmic membrane, maintains cell shape and integrity, and prevents cell
lysis from high osmotic pressure.
The cell wall is composed of a complex
cross-linked polymer of polysaccharides and polypeptides, peptidoglycan
(murein, mucopeptide).
The polysaccharide
contains alternating amino sugars, N-acetylglucosamine (NAGA), and N-acetylmuramic
acid (NAMA).
A five-amino-acid
peptide is linked to the N-acetyl muramic acid sugar. This peptide
terminates in D-alanyl-D-alanine.
Penicillin-binding protein (PBP, an enzyme
transpeptidases / endopeptidases / carboxypeptidases)) removes the terminal
alanine in the process of forming a cross-link with a nearby peptide.
Cross-links give the cell wall its structural
rigidity.
β-lactam
antibiotics covalently bind to the active site of PBPs. This inhibits the
transpeptidation reaction, halting peptidoglycan synthesis, and the cell dies.
β-lactams kill
bacterial cells only when they are actively growing and synthesizing cell wall.
Mechanism of
action
ß-lactam antibiotics are
bactericidal drugs. They inhibit cell wall synthesis by the following steps:
1- Binding of the drug to
specific receptors (penicillin-binding proteins, PBPs)
2- Inhibition of
transpeptidases that act to cross-link linear peptidoglycan chains that form
part of the cell wall.
3- Activation of autolytic enzymes that cause lyses of the bacterial
cell wall.
•
Interferes with
last step of bacterial cell wall synthesis, causing cell lysis
•
Bactericidal
•
Only effective
against rapidly growing organisms that synthesize a peptidoglycan cell wall
•
Inactive against
mycobacteria, fungi, viruses
Mechanism of Action way of being bactericide
•
Penicillin binding
proteins
–
Enzymes involved
in forming cross linkages between peptidoglycan chains inactivated by
penicillin
•
Inhibition of
transpeptidase
–
Hinders last step
in formation of cross links needed for cell wall integrity
•
Autolysins
–
Normally degrade
cell wall, but penicillin prevents new synthesis
The transpeptidation reaction in Staphylococcus
aureus that is inhibited by β-lactam
antibiotics. The cell wall of gram-positive bacteria is made up of long
peptidoglycan polymer chains consisting of the alternating aminohexoses N-acetylglucosamine
(G) and N-acetylmuramic acid (M) with pentapeptide side chains linked
(in S aureus) by pentaglycine bridges. The exact composition of the side
chains varies among species. The diagram illustrates small segments of two such
polymer chains and their amino acid side chains. These linear polymers must be
cross-linked by transpeptidation of the side chains at the points indicated by
the asterisk to achieve the strength necessary for cell viability.
The biosynthesis of cell wall peptidoglycan,
showing the sites of action of five antibiotics (shaded bars; 1
= fosfomycin, 2 = cycloserine, 3 = bacitracin, 4
= vancomycin, 5 = -lactam antibiotics). Bactoprenol (BP) is the lipid
membrane carrier that transports building blocks across the cytoplasmic
membrane; M, N-acetylmuramic acid; Glc, glucose; NAcGlc or G, N-acetylglucosamine.
Bacterial Resistance
- β-lactamase activity
•
Hydrolyzes cyclic
amide bond of b-lactam ring
•
Usually acquired
by transfer of plasmids
- Decreased permeability to drug
- Altered penicillin binding proteins
•
May require
greater antibiotic concentrations
- Efflux
Pharmacokinetic Features
Absorption
Most penicillins in aqueous solution are rapidly
absorbed from parenteral sites.
Absorption is delayed when the inorganic penicillin
salts are suspended in vegetable oil vehicles or when the sparingly soluble
repository organic salts (eg, procaine penicillin G and benzathine penicillin
G) are administered parenterally.
Although prolonged absorption results in longer
persistence of plasma and tissue drug concentrations, peak concentrations may
not be sufficiently high to be effective against organisms unless MIC are low.
The penicillin G repositol salts should never be injected
IV.
Only selected penicillins are acid stable and can be
administered PO at standard doses. Absorption from the upper GI tract differs
markedly in amount and rate among the various penicillins. Penicillin V must be
given at high oral doses.
The aminopenicillins are orally bioavailable,
although food impairs the absorption of ampicillin.
The indanyl form of carbenicillin is orally
bioavailable, but effective concentrations are likely to be achieved only
in the urine.
Serum concentrations of penicillins generally peak
within 2 hr of PO administration. Penicillins may also be absorbed after
intrauterine infusion.
Distribution
After absorption, penicillins are widely distributed
in body fluids and tissues.
The volume of distribution tends to reflect
extracellular compartmentalization, although some penicillins penetrate into
tissues quite well.
Potentially therapeutic concentrations of the various
penicillins are generally found in the liver, bile, kidneys, intestines,
muscle, and lungs, but only very low concentrations are found in poorly
perfused areas such as the cornea, bronchial secretions, cartilage, and bone.
The diethylamino salt of penicillin G produces
particularly high concentrations in pulmonary tissue.
The penicillins usually do not readily cross the
normal blood-brain, placental, mammary, or prostatic barriers unless massive
doses are given or inflammation is present.
Selected penicillins are able to penetrate nonchronic
abscesses and pleural, peritoneal, or synovial fluids.
Penicillins are reversibly and loosely bound to
plasma proteins. The extent of this binding varies with particular penicillins
and their concentration, eg, ampicillin is usually ∼20% bound, and cloxacillin may be ∼80% bound.
Pregnancy increases the volume of distribution, which
has the effect of lowering the concentration of drug produced by a given dose.
Biotransformation
Penicillins are generally excreted unchanged, but
fractions of a given dose may undergo metabolic transformations by unknown
mechanisms (usually <20% metabolized).
Penicilloic acid derivatives that are formed tend to
be allergenic.
Excretion
Most (60–90%) of a parenterally administered
penicillin is eliminated in the urine within a short time (eg, up to 90% of
penicillin G within 6 hr), which results in high concentrations in urine.
About 20% of renal excretion occurs by glomerular
filtration and ∼80% by tubular secretion—a process that may be deliberately inhibited (to
prolong effective concentrations in the body) by probenecid and other weak
organic acids.
Anuria may increase the half-life of penicillin G
(normally ∼30 min) to 10 hr.
The biliary route also may be a major excretory
pathway for the broad-spectrum semisynthetic penicillins. Clearance is
considerably lower in neonates than in adults.
Penicillins are also eliminated in milk, although
often only in trace amounts in the normal udder, and may persist for up to 90
hr. Penicillin residues in milk also have been found after intrauterine
infusion.
Elimination, Distribution, and Clearance
of Penicillins
|
||||
Penicillin
|
Species
|
Elimination Half-life (min)
|
Volume of Distribution (mL/kg)
|
Clearance (mL/kg/min)
|
Penicillin
G
|
Dogs
|
30
|
156
|
3.6
|
Horses
|
38
|
301
|
5.5
|
|
Ampicillin
|
Dogs
|
48
|
270
|
3.9
|
Amoxicillin
|
Cattle
|
84
|
493
|
4.0
|
Ticarcillin
|
Dogs
|
48
|
347
|
4.9
|
Carbenicillin
|
Cattle
|
122
|
330
|
5.5
|
One std. Unit of penicillin is
defined as the amount of antibacterial activity present in 0.6 µgm of pure
crystalline standard sodium penicillin G.
1 mg = 1667 oxford units.
The dosage of semi-synthetic
penicillins is expressed in mg/kg.
Specific Indications for Penicillins
•
Narrow-spectrum
bactericidal
•
Most Gm+ cocci and
rods and anaerobes
•
Intravenous: Pen G
(potassium or sodium)
•
Intramuscular:
Benzathine or procaine Pen G
•
Oral: Pen V
•
Pen V, G well
distributed in soft tissues
•
Bone level is
fraction of plasma concentration
•
Excreted primarily
via kidneys
Special
Clinical Concerns
Adverse Effects and Toxicity: Organ
toxicity is rare.
Hypersensitivity reactions (particularly in cattle)
include skin reactions, angioedema, drug fever, serum sickness, vasculitis,
eosinophilia, and anaphylaxis. Cross-sensitivity among penicillins is well
recognized.
Intrathecal administration may result in convulsions.
Guinea pigs, chinchillas, birds, snakes, and turtles
are sensitive to procaine penicillin.
The use of broad-spectrum penicillins may lead to
superinfection, and GI disturbances may occur after PO administration of
ampicillin.
Potassium penicillin G should be administered IV with
some caution, especially if hyperkalemia is present.
The sodium salt of penicillin G may also contribute
to the sodium load in congestive heart failure.
Adverse Reactions
•
Hypersensitivity-
1-10% patients treated
–
Penicilloic acid-
hapten for immune reaction
–
Urticaria to
angioedema to anaphylaxis
–
b-lactam cross
reactivity
•
Diarrhea-
disruption of flora- ampicillin
•
Nephritis-
methicillin
•
Neurotoxicity-
intrathecal or seizure disorders
•
Platelet
dysfunction- carbenicillin, ticarcillin
•
Cation toxicity-
watch sodium (congenstive heart failure) and potassium (cardiac toxicity esp in
renal failure pts)
•
Skin
rashes-ampicillin and amoxicillin
Allergic Reactions
•
Acute (< 30
min)
–
Urticaria,
angioedema, bronchoconstriction, shock
•
Accelerated (30
min-48 hrs)
–
Urticaria,
pruritis, wheezing, mild laryngeal edema, local inflammatory reactions
•
Delayed (> 2
days)
–
Skin rash
–
Oral glossitis,
flurred tongue, black and brown tongue, cheilosis, severe stomatitis with loss
buccal mucosa
•
Mild: Diphenhydramine
25-50 mg IV/IM/PO
•
Severe:
Epinephrine 0.03-0.05 mg
•
Skin tests:
benzylpenicilloyl-polylysine
Interactions
Tubular secretion is delayed in the presence of
selected organic ions, including salicylates, phenylbutazone, sulfonamides, and
other weak acids.
Gut-active penicillins potentiate the action of
anti-coagulants by depressing vitamin K production by gut flora.
Absorption of
ampicillin is impaired by the presence of food.
β-lactams in general interact chemically with the
aminoglycosides and should not be mixed in vitro.
Ampicillin and penicillin G are incompatible with
many other drugs and solutions and should not be mixed.
Penicillins and Aminoglycosides
•
Synergistic
• Inactivate each other if placed in same IV
fluid bag because of positively charged aminoglycosides and negative
penicillins
β-lactamase Inhibitors
•
Clavulanic acid:
product of streptomyces clavuligerus
•
Irreversibly binds
b-lactamases and inactivates them
•
Augmentin:
amoxicillin + clavulanic acid
•
Timentin:
ticarcillin + clavulanic acid
•
Unasyn: ampicillin
+ sulbactam
Comments
Post a Comment